Cosmetic

Japan Cosmetics Compliance & Market Entry Services

Updated on

Bringing cosmetics to the Japanese market requires more than completing a single “registration.” The first step is to determine whether the product is regulated as a cosmetic or a quasi-drug under Japan’s Pharmaceuticals and Medical Devices Act (PMD Act), because the two categories follow different market-entry pathways.

REACH24H supports overseas brands, manufacturers, OEM/ODM companies, importers and distributors in assessing product classification, identifying the applicable Japan market-entry pathway, preparing required notifications or quasi-drug approval materials, and addressing formula, labeling and claims compliance.

If you are preparing a Japan launch, you can start by providing your product type, intended use, formula, proposed claims, manufacturing information and planned Japan sales model. REACH24H can review this information to identify the likely regulatory pathway and initial compliance gaps.

Do Cosmetics Need Registration or Approval in Japan?

General cosmetics that comply with Japan’s Standards for Cosmetics generally do not require product-by-product marketing approval. However, companies still need an appropriately licensed Japan-side Marketing Authorization Holder (MAH), applicable notifications, formula compliance, labeling and advertising controls.

The PMDA Frequently Asked Questions on Cosmetics confirms that marketing approval is generally not required for cosmetics complying with the Standards for Cosmetics, while products containing active ingredients are generally classified as quasi-drugs and require marketing approval.

Japan Cosmetics vs. Quasi-Drugs: Which Path Applies?

A product marketed as a cosmetic in the United States, European Union, China or another market is not automatically classified in the same way in Japan. Classification under the PMD Act depends on factors including the product’s intended purpose, action, formulation, method of use and proposed claims.

Regulatory Point

Cosmetics

Quasi-Drugs

General regulatory position

Products intended to cleanse, beautify, alter appearance or maintain skin or hair in good condition, with mild action on the human body

A separate PMD Act category covering specified purposes and designated product types, also with mild action on the human body

Product marketing approval

Generally not required when the product complies with the Standards for Cosmetics

Generally required, subject to the applicable quasi-drug category and pathway

Key formula consideration

Compliance with the Standards for Cosmetics and other applicable ingredient requirements

Active ingredients, formulation and applicable quasi-drug standards or approval requirements

Claims

Must remain within the scope permitted for cosmetics

Must be consistent with the relevant quasi-drug category and approved product particulars

Typical market-entry focus

Classification, formula review, MAH, applicable notifications, C73 notification for foreign cosmetic marketers/manufacturers where applicable, labeling and advertising

Classification, approval strategy, technical dossier, applicable testing, Japan-side licensing arrangements, labeling and post-market responsibilities

Under the PMD Act, cosmetics are generally products intended for purposes such as cleansing, beautifying, altering appearance, or maintaining skin or hair in good condition, with mild action on the human body. Quasi-drugs are a separate legal category covering specified purposes and designated products. Companies can review the broader regulatory framework through the MHLW Cosmetics and Quasi-Drugs information portal.

A product’s classification in Japan can affect the applicable regulatory pathway, documentation requirements and testing strategy. REACH24H can review the product type, formula and proposed claims to help identify the appropriate pathway.

Key Japan Cosmetics Compliance Requirements

Japan market entry normally involves several connected regulatory workstreams rather than one isolated registration procedure.

Product Classification and Regulatory Pathway

The product’s intended use, formulation, active ingredients where relevant, method of use and proposed claims should be assessed before the regulatory pathway is finalized.

Classification should be addressed early because it can affect whether product approval is required, the applicable formula and technical requirements, Japan-side licensing arrangements, claims, documentation and project planning.

PMDA also advises that product classification needs to be determined for the individual product and that companies should confirm applicable requirements with the relevant Japan-side MAH or competent authority where necessary. See the PMDA regulatory FAQ.

Formula and Ingredient Compliance

Cosmetics marketed in Japan must comply with the Standards for Cosmetics issued by the Ministry of Health, Labour and Welfare (MHLW).

The framework includes prohibited and restricted ingredients as well as positive-list controls for categories such as preservatives and UV absorbers. The JCIA overview of Japan cosmetic compliance requirements also summarizes the negative- and positive-list framework.

REACH24H can review a complete formula against applicable Japanese requirements, identify potential restrictions or formulation issues, and check whether suitable Japanese cosmetic ingredient labeling names are available.

A formula that is already compliant in the EU, United States or another market should still be assessed against Japanese requirements before launch.

Japan-Side Marketing Authorization Holder and Licensing

Cosmetics and quasi-drugs must be marketed in Japan through an entity holding the appropriate marketing license. In this page, this licensed Japan-side entity is referred to as the Marketing Authorization Holder (MAH).

According to JCIA guidance on cosmetic marketing, the marketing business involves placing manufactured or imported products on the market while assuming responsibility for product quality, efficacy and safety. The applicable marketing business requires authorization from the prefectural governor and compliance with relevant quality and post-marketing safety management requirements.

The MAH is different from the physical manufacturer. If activities such as packaging, labeling or storage are carried out in Japan, manufacturing licensing requirements may also apply. JCIA guidance on cosmetic manufacturing specifically explains that packaging, labeling and storage are included within manufacturing activities under the PMD Act.

REACH24H can review the planned import, manufacturing and distribution structure and support companies in identifying and coordinating the applicable Japan-side entity and licensing workstreams.

Cosmetic Notifications and Quasi-Drug Approval

General Cosmetics

General cosmetics that do not require product marketing approval are still subject to applicable notification procedures before market entry.

For cosmetics manufactured outside Japan, a C73 notification for foreign cosmetic marketers/manufacturers may also be required. PMDA’s current C73 guidance states that, when cosmetics manufactured overseas are imported and marketed in Japan, information concerning the relevant foreign entity engaged in marketing or manufacturing the cosmetics must be notified to the Minister of Health, Labour and Welfare.

Companies can review the official requirements through the PMDA C73 guidance for foreign cosmetic marketers/manufacturers.

The C73 notification for foreign cosmetic marketers/manufacturers is a notification procedure. It should not be described as product marketing approval or as a foreign cosmetic manufacturer registration license, and it does not replace other requirements applicable to the product or Japan-side MAH.

Quasi-Drugs

Quasi-drugs generally require product marketing approval. The applicable pathway and technical package can depend on factors such as product category, active ingredients, formulation, applicable standards and available technical evidence.

The PMDA cosmetics FAQ notes that products containing active ingredients are generally classified as quasi-drugs in Japan and require an application for marketing approval.

REACH24H can support regulatory pathway assessment, dossier gap analysis, technical documentation planning, application preparation and regulatory communication. Where additional testing or supporting evidence is needed, the testing strategy should be determined after the product pathway and available data have been reviewed.

Japanese Cosmetic Ingredient Labeling Names

Cosmetics marketed in Japan require full ingredient labeling using appropriate Japanese Labeling Names for Cosmetic Ingredients.

The JCIA guidance on cosmetic ingredient labeling explains that ingredient names used for full-ingredient labeling are taken from the List of Japanese Labeling Names for Cosmetics prepared by JCIA and other applicable sources.

The term “Japanese INCI name” is often used commercially, but a Japanese Labeling Name is not simply a Japanese translation of an INCI name.

If no suitable Japanese Labeling Name is available, an application to the Japan Cosmetic Industry Association (JCIA) may be needed. JCIA states that the ingredient must already have obtained an INCI name or have an INCI name application in progress.

REACH24H can support existing-name checks and Japanese Cosmetic Ingredient Labeling Name application support where required.

Labeling, Claims and Advertising Compliance

Japanese cosmetic labeling should be reviewed against applicable Japanese requirements rather than handled as a direct translation of an overseas label.

Under the PMD Act, required information on the immediate container or packaging can include the name and address of the marketing authorization holder, product name, lot or manufacturing code, applicable ingredient information and other required particulars depending on the product.

Advertising and product claims also require Japan-specific review. The PMD Act prohibits false or exaggerated advertising, while ordinary cosmetic claims must remain within the applicable cosmetic efficacy scope. Quasi-drug claims need to be evaluated against the relevant product category and approved particulars.

The JCIA guidance on appropriate cosmetic advertising explains Japan’s advertising framework and the role of JCIA’s voluntary guidelines. JCIA is an industry association rather than a government regulator.

REACH24H can review labels, e-commerce content, marketing copy and proposed claims through a broader market-entry project or its dedicated Cosmetics Advertising Compliance in Japan service.

How REACH24H Supports Japan Cosmetic Market Entry

The exact scope of a Japan cosmetics or quasi-drug project should be determined after the product classification, formula, manufacturing model and Japan-side business arrangement are understood.

Service

Client Need

Typical REACH24H Support

Product classification and pathway assessment

Determine whether the product should follow a cosmetic or quasi-drug pathway

Product review, regulatory pathway assessment and initial compliance gap identification

Formula and ingredient compliance review

Determine whether the existing formula can be used in Japan

Ingredient screening, formula review and identification of potential compliance issues

Japan-side entity and licensing pathway support

Determine the required Japan-side regulatory setup

Review of the marketing, importing and manufacturing model and coordination of applicable licensing workstreams

General cosmetics market-entry support

Complete applicable pre-market procedures

Preparation and coordination of applicable cosmetic notifications and the C73 notification for foreign cosmetic marketers/manufacturers where relevant

Quasi-drug approval support

Prepare for product marketing approval

Pathway assessment, dossier gap analysis, technical documentation, application preparation and regulatory follow-up

Japanese Labeling Name support

Obtain an appropriate Japanese ingredient labeling name

Existing-name check and application support where required

Label, claims and advertising review

Prepare compliant Japanese market materials

Label and promotional-content review with recommended revisions

Post-market regulatory support

Address regulatory changes and ongoing compliance needs

Case-specific regulatory maintenance and follow-up support

Japan Cosmetic Market Entry Process

The following project flow illustrates how REACH24H can coordinate a Japan market-entry project. It is a project workflow rather than a fixed statutory procedure for every product.

Step 1 — Initial Product Assessment

REACH24H reviews the product type, intended use, formula, claims, manufacturing information and planned Japan sales model.

Step 2 — Classification and Compliance Gap Analysis

The applicable cosmetic or quasi-drug pathway is assessed, together with major formula, Japan-side MAH, notification or approval, labeling, claims and technical-data requirements.

Step 3 — Regulatory and Technical Preparation

Depending on the identified pathway, this stage may involve formula adjustment, Japanese Labeling Name checks, Japan-side licensing coordination, notification documentation, quasi-drug dossier preparation or additional evidence planning.

Step 4 — Notification or Approval Support

For general cosmetics, REACH24H supports applicable notification procedures, including the C73 notification for foreign cosmetic marketers/manufacturers where relevant. For quasi-drugs, REACH24H supports preparation and execution of the applicable product marketing approval pathway.

Step 5 — Label, Launch and Post-Market Support

Before commercialization, relevant Japanese labeling and promotional claims can be reviewed. REACH24H can also support subsequent regulatory updates and post-market compliance matters.

What Documents and Testing May Be Required?

The information needed for project execution depends on whether the product follows a general cosmetic or quasi-drug pathway. The lists below describe typical project information and should not be interpreted as a universal dossier checklist.

General Cosmetics

For general cosmetics, relevant information commonly includes:

  • Complete formulation and ingredient information;

  • Information required for applicable marketing notifications;

  • Foreign manufacturer and manufacturing-site information;

  • Available product quality and safety supporting information;

  • Japanese label and full ingredient list;

  • Proposed advertising and efficacy claims.

General cosmetics normally do not require a product marketing approval dossier when they comply with the Standards for Cosmetics. The licensed Japan-side MAH nevertheless remains responsible for areas including product quality and post-marketing safety management.

There is no single pre-market testing package that should automatically be ordered for every general cosmetic. Existing evidence should first be reviewed against the product characteristics, formula, intended use, claims and responsibilities of the Japan-side MAH.

Quasi-Drugs

Quasi-drug approval projects may require a more extensive technical package. Depending on the product category and application pathway, relevant information may include:

  • Product development and overseas-use information;

  • Complete formulation and active ingredient information;

  • Manufacturing information;

  • Product specifications and test methods;

  • Stability and safety information;

  • Efficacy-supporting information;

  • Manufacturing-site and quality information;

  • Japanese application documents.

The exact data package is not identical for every quasi-drug. The application pathway and existing evidence should therefore be assessed before a testing or dossier strategy is finalized.

How Long Does Japan Cosmetic Compliance Take and What Does It Cost?

There is no single processing time or project cost that applies to every Japan cosmetics compliance project.

For general cosmetics, project timing and cost can be influenced by factors such as:

  • Readiness of the Japan-side MAH and applicable licenses;

  • Formula compliance or reformulation needs;

  • Applicable product notifications and the C73 notification for foreign cosmetic marketers/manufacturers;

  • Availability of Japanese Labeling Names;

  • Label and claims revisions;

  • Completeness of manufacturer and supply-chain information.

For quasi-drugs, additional variables can include:

  • Product and application category;

  • Active ingredients and formulation;

  • Available technical evidence;

  • Need for additional testing;

  • Completeness of the application package;

  • Questions or additional information requests arising during regulatory review.

REACH24H assesses the applicable regulatory route and available documentation before defining the project scope, expected project schedule and service quotation.

Why Choose REACH24H for Japan Cosmetics Compliance?

Local Subsidiary in Tokyo for Japan-Side Coordination

REACH24H operates REACH24H JAPAN Co., Ltd. in Tokyo, providing local support for overseas brands, manufacturers and regulatory teams entering the Japanese market.

The Japan team works together with REACH24H’s international cosmetic compliance specialists to support Japan-side regulatory communication, documentation coordination and project implementation. This local presence helps overseas companies bridge language, documentation and regulatory practice differences when working with Japanese entities and authorities.

42 Dedicated Cosmetic Compliance Experts for Integrated Technical Support

As of August 2026, REACH24H’s cosmetic compliance team consists of 42 dedicated technical experts, with expertise covering regulatory assessment, formula and ingredient compliance, toxicology, cosmetic safety assessment, efficacy evaluation, labeling and regulatory dossier review.

For Japan market entry, these capabilities can be coordinated within one project across product classification, formula review, Japanese ingredient labeling names, testing considerations, notifications or quasi-drug approval requirements, labeling and advertising compliance.

This integrated approach helps identify regulatory and technical dependencies at an early stage rather than addressing each compliance requirement separately.

9 Global Branches Supporting Cross-Market Documentation Alignment

REACH24H operates 9 branches and local teams across Asia, Europe and North America, including Tokyo, Seoul, Singapore, Hanoi, Dublin, London and Washington, D.C.

Companies entering Japan often already hold formulas, ingredient documentation, labels, safety information, test reports or regulatory files prepared for other markets. REACH24H can review these existing materials against Japan-specific requirements, identify which information may remain usable and determine where market-specific adjustment or additional documentation is needed.

For companies planning launches in several jurisdictions, the same core product information package can also be coordinated through REACH24H’s Global Cosmetic Compliance Services.

2,000+ Cosmetics Companies Supported Worldwide

As of August 2026, REACH24H has provided regulatory compliance and market access services in one or more jurisdictions to more than 2,000 cosmetics-related companies worldwide, including multinational cosmetic groups and global brands.

This project experience covers both single-market entry and multi-market product launches, enabling REACH24H to support companies not only with Japan-specific compliance requirements, but also with the coordination of product classification, ingredient compliance, labeling, safety documentation and regulatory pathways across multiple target markets.

Frequently Asked Questions About Japan Cosmetics Compliance

Do cosmetic products need registration or PMDA approval in Japan?

General cosmetics complying with the Standards for Cosmetics generally do not require product-by-product marketing approval. However, Japan-side marketing licensing, applicable notifications, the C73 notification for foreign cosmetic marketers/manufacturers where relevant, formula compliance, labeling and advertising still need to be addressed. Quasi-drugs generally require marketing approval.

Does an overseas cosmetic brand need a Japanese MAH?

Cosmetics must be marketed through a Japan-side entity holding the appropriate marketing license. This licensed MAH assumes responsibilities including quality and post-marketing safety management. The appropriate setup depends on the company’s importing, manufacturing and distribution model.

What is the C73 notification for foreign cosmetic marketers/manufacturers?

The C73 notification for foreign cosmetic marketers/manufacturers is a notification concerning relevant foreign entities when cosmetics manufactured overseas are imported and marketed in Japan. PMDA provides dedicated instructions for the C73 procedure. It is a notification rather than product marketing approval or a foreign manufacturer registration license.

How can I determine whether my product is a cosmetic or quasi-drug?

Classification depends on the product’s intended purpose, action, formulation, method of use, active ingredients where relevant, and proposed claims. Classification in another jurisdiction does not automatically determine the Japanese regulatory category. PMDA recommends confirming the applicable classification and requirements for the individual product where necessary.

Can I use the same EU or U.S. cosmetic formula in Japan?

Not automatically. The formulation must comply with Japan’s Standards for Cosmetics and other applicable Japanese ingredient requirements. An EU- or U.S.-compliant formula should therefore still be screened before the product is prepared for the Japanese market.

Do cosmetics in Japan need “Japanese INCI names”?

Japan uses Japanese Labeling Names for Cosmetic Ingredients for full ingredient labeling. Although “Japanese INCI” is a commonly used commercial term, Japanese Labeling Names are not simply Japanese translations of INCI names. If no suitable name exists, an application to JCIA may be needed.

Is testing mandatory for every cosmetic entering Japan?

There is no single universal pre-market testing package for every general cosmetic. The need for supporting evidence should be assessed according to the product, formula, existing quality and safety information, intended claims and regulatory pathway. Quasi-drug projects may involve additional product-specific testing or technical evidence.

Can claims such as whitening, anti-acne or anti-hair-loss be used in Japan?

It depends on the product classification, exact wording and advertising context. General cosmetic claims must remain within the applicable cosmetic efficacy and advertising scope, while quasi-drug claims need to align with the relevant product category and approved particulars. The PMD Act also prohibits false or exaggerated advertising.

Plan Your Japan Cosmetics Compliance Project

Before selecting a filing route, ordering additional testing or finalizing Japanese packaging, confirm the product classification and regulatory workstreams that apply to your specific product.

Send REACH24H your product type, quantitative formula, intended claims, manufacturing information, existing technical data and planned Japan sales model. The team can review the information and discuss the appropriate scope for your Japan cosmetics or quasi-drug market-entry project.

REACH24H Cosmetic Compliance Team

Written by

REACH24H Cosmetic Compliance Team

REACH24H

Founded in 2009, the cosmetic compliance team of REACH24H boasts over 40 professional technical experts. The team includes multiple internationally certified toxicologists, EU-qualified cosmetic safety assessors, risk assessment specialists, cosmetic formulators, regulatory analysts, as well as overseas high-caliber talents proficient in multiple languages. We deliver professional and efficient technical services and customized solutions, assisting cosmetic enterprises worldwide to smoothly access target markets.

Newsletter Subscription

Sign up to receive event invitations, expert insights, timely news alerts, and other updates.

SUBSCRIBE

Contact Us

REACH24H USA

+1 703 596 8055

REACH24H EU

+353 1 8899 951

REACH24H UK

+44 782 7193124

REACH24H China

+86 571 87103805

REACH24H Korea

+82 2 62451610

REACH24H Japan

+03 5005 0662

REACH24H Singapore

Related Services

Events

China's New Cosmetic Ingredient Regulations: Key Changes and Compliance Strategies Navigating Malaysia's Cosmetic Regulatory Requirements
Full Image

We use cookies to ensure that you have the best browsing experience on our website, analyze the relevance between you and our content, and further understand our privacy policy.